Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero's lead product, an ...

Xcellerex, Inc. announced today that Guy Broadbent has been appointed President and Chief Executive Officer and a member of the company's board of directors. Mr. Broadbent succeeds Joseph Zakrzewski, ...

Xcellerex, Collaborators Receive $11 Million Phase 2 U.S. Contract to Develop Technology for Accelerated Monoclonal Antibody and Vaccine Manufacturing MARLBORO, Mass.--(BUSINESS WIRE)--Xcellerex, Inc.

Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...

Xcellerex is revolutionizing the way biomolecules are developed, manufactured, and commercialized. The company’s unique single-use technology platform transforms biomanufacturing economics, enabling ...

Gallus Acquiring FlexFactory® Bioproduction Lines and Single-Use Bioreactors; Xcellerex Partners to Help Customers Gain Access to Commercial Biomanufacturing Facility MARLBOROUGH, Mass. & ST.

Xcellerex, Inc. received two Phase-I contracts from the Defense Advanced Research Projects Agency (Arlington, VA) for the Accelerated Manufacture of Pharmaceuticals program. Phase I of the AMP program ...

On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount. On Mar. 7, 2012, GE ...

Xcellerex Inc., a privately held provider of manufacturing systems for biotherapeutics and vaccines, has begun a Phase 1 clinical trial of its yellow fever vaccine, XRX-001. The company said it is ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in ...

GE Healthcare has announced it has reached an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, according to a news release (pdf). Xcellerex ...